These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 1959888)
1. Autoantibody against dihydrolipoamide dehydrogenase, the E3 subunit of the 2-oxoacid dehydrogenase complexes: significance for primary biliary cirrhosis. Maeda T; Loveland BE; Rowley MJ; Mackay IR Hepatology; 1991 Dec; 14(6):994-9. PubMed ID: 1959888 [TBL] [Abstract][Full Text] [Related]
2. Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis. Van de Water J; Cooper A; Surh CD; Coppel R; Danner D; Ansari A; Dickson R; Gershwin ME N Engl J Med; 1989 May; 320(21):1377-80. PubMed ID: 2716784 [TBL] [Abstract][Full Text] [Related]
3. Autoantibodies in primary biliary cirrhosis: analysis of reactivity against eukaryotic and prokaryotic 2-oxo acid dehydrogenase complexes. Fussey SP; Lindsay JG; Fuller C; Perham RN; Dale S; James OF; Bassendine MF; Yeaman SJ Hepatology; 1991 Mar; 13(3):467-74. PubMed ID: 1999318 [TBL] [Abstract][Full Text] [Related]
4. Antimitochondrial antibodies of primary biliary cirrhosis recognize dihydrolipoamide acyltransferase and inhibit enzyme function of the branched chain alpha-ketoacid dehydrogenase complex. Fregeau DR; Davis PA; Danner DJ; Ansari A; Coppel RL; Dickson ER; Gershwin ME J Immunol; 1989 Jun; 142(11):3815-20. PubMed ID: 2715637 [TBL] [Abstract][Full Text] [Related]
5. Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide dehydrogenase-binding protein (E3BP) and the glycine cleavage proteins in primary biliary cirrhosis. Dubel L; Tanaka A; Leung PS; Van de Water J; Coppel R; Roche T; Johanet C; Motokawa Y; Ansari A; Gershwin ME Hepatology; 1999 Apr; 29(4):1013-8. PubMed ID: 10094940 [TBL] [Abstract][Full Text] [Related]
6. Biochemistry and autoimmune response to the 2-oxoacid dehydrogenase complexes in primary biliary cirrhosis. Bassendine MF; Jones DE; Yeaman SJ Semin Liver Dis; 1997 Feb; 17(1):49-60. PubMed ID: 9089910 [TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope. Leung PS; Chuang DT; Wynn RM; Cha S; Danner DJ; Ansari A; Coppel RL; Gershwin ME Hepatology; 1995 Aug; 22(2):505-13. PubMed ID: 7543435 [TBL] [Abstract][Full Text] [Related]
8. Autoantibodies of sera from patients with primary biliary cirrhosis recognize the alpha subunit of the decarboxylase component of human branched-chain 2-oxo acid dehydrogenase complex. Mori T; Ono K; Hakozaki M; Kasukawa R; Kochi H J Hepatol; 2001 Jun; 34(6):799-804. PubMed ID: 11451161 [TBL] [Abstract][Full Text] [Related]
9. Enzyme inhibitory autoantibodies to pyruvate dehydrogenase complex in primary biliary cirrhosis differ for mammalian, yeast and bacterial enzymes: implications for molecular mimicry. Teoh KL; Mackay IR; Rowley MJ; Fussey SP Hepatology; 1994 Apr; 19(4):1029-33. PubMed ID: 8138243 [TBL] [Abstract][Full Text] [Related]
10. Sjögren's syndrome and primary biliary cirrhosis: presence of autoantibodies to purified mitochondrial 2-OXO acid dehydrogenases. Fujikura S; Davis PA; Prindiville T; Leung P; Fox RI; Gershwin ME J Rheumatol; 1990 Nov; 17(11):1453-7. PubMed ID: 1703233 [TBL] [Abstract][Full Text] [Related]
11. Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis. Van de Water J; Ansari AA; Surh CD; Coppel R; Roche T; Bonkovsky H; Kaplan M; Gershwin ME J Immunol; 1991 Jan; 146(1):89-94. PubMed ID: 1984455 [TBL] [Abstract][Full Text] [Related]
12. [The association between autoantibodies to enzyme and diseases--with special reference to antibodies to pyruvate dehydrogenase complex (PDH)]. Moteki S; Amaki S; Nakano E Rinsho Byori; 1998 Apr; 46(4):317-23. PubMed ID: 9594621 [TBL] [Abstract][Full Text] [Related]
13. Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex. Moteki S; Leung PS; Dickson ER; Van Thiel DH; Galperin C; Buch T; Alarcon-Segovia D; Kershenobich D; Kawano K; Coppel RL Hepatology; 1996 Mar; 23(3):436-44. PubMed ID: 8617422 [TBL] [Abstract][Full Text] [Related]
14. Immunoreactivity of antimitochondrial autoantibodies in Japanese patients with primary biliary cirrhosis. Omagari K; Rowley MJ; Jois JA; Feeney SJ; Komatsu K; Maeda T; Onishi S; Yamazaki K; Suzuki K; Galperin C; Mackay IR J Gastroenterol; 1996 Feb; 31(1):61-8. PubMed ID: 8808430 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of alpha-ketoglutarate dehydrogenase activity by a distinct population of autoantibodies recognizing dihydrolipoamide succinyltransferase in primary biliary cirrhosis. Fregeau DR; Prindiville T; Coppel RL; Kaplan M; Dickson ER; Gershwin ME Hepatology; 1990 Jun; 11(6):975-81. PubMed ID: 2365294 [TBL] [Abstract][Full Text] [Related]
16. In situ nucleic acid detection of PDC-E2, BCOADC-E2, OGDC-E2, PDC-E1alpha, BCOADC-E1alpha, OGDC-E1, and the E3 binding protein (protein X) in primary biliary cirrhosis. Harada K; Sudo Y; Kono N; Ozaki S; Tsuneyama K; Gershwin ME; Nakanuma Y Hepatology; 1999 Jul; 30(1):36-45. PubMed ID: 10385636 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the autoantibody responses to recombinant E3 binding protein (protein X) of pyruvate dehydrogenase in primary biliary cirrhosis. Palmer JM; Jones DE; Quinn J; McHugh A; Yeaman SJ Hepatology; 1999 Jul; 30(1):21-6. PubMed ID: 10385634 [TBL] [Abstract][Full Text] [Related]
18. Molecular basis of mitochondrial autoreactivity in primary biliary cirrhosis. Mackay IR; Gershwin ME Immunol Today; 1989 Sep; 10(9):315-8. PubMed ID: 2480138 [TBL] [Abstract][Full Text] [Related]
19. Autoantibodies of primary biliary cirrhosis recognize dihydrolipoamide acetyltransferase and inhibit enzyme function. Van de Water J; Fregeau D; Davis P; Ansari A; Danner D; Leung P; Coppel R; Gershwin ME J Immunol; 1988 Oct; 141(7):2321-4. PubMed ID: 3049806 [TBL] [Abstract][Full Text] [Related]
20. Humoral and cellular immune responses to dihydrolipoamide dehydrogenase (E3): lack of specificity for primary biliary cirrhosis. Tanaka H; Maeda T; Onishi S; Yamamoto Y Liver; 1995 Jun; 15(3):121-5. PubMed ID: 7674838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]